Published in J Hepatobiliary Pancreat Surg on February 16, 2008
Extra-Glissonian approach in liver resection. HPB (Oxford) (2010) 1.10
Diagnosis and management of gallbladder cancer. N Am J Med Sci (2012) 0.95
Prognostic factors for gallbladder cancer in the laparoscopy era. J Korean Surg Soc (2012) 0.95
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. Oncotarget (2013) 0.94
The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? HPB (Oxford) (2011) 0.92
Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol (2013) 0.90
Gallbladder cancer: we need to do better! Ann Surg Oncol (2009) 0.88
A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer. Int J Clin Oncol (2013) 0.88
Practical guidelines for the surgical treatment of gallbladder cancer. J Korean Med Sci (2014) 0.85
Extrahepatic biliary cancer: New staging classification. World J Radiol (2012) 0.84
Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy. World J Gastrointest Oncol (2013) 0.84
Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma. Surg Endosc (2015) 0.82
Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis. World J Gastroenterol (2013) 0.82
Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma. J Korean Surg Soc (2013) 0.82
Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives. ISRN Hepatol (2014) 0.81
Invasion of the hepatic artery is a crucial predictor of poor outcomes in gallbladder carcinoma. World J Surg (2012) 0.81
Pancreatoduodenectomy for bile duct and ampullary cancer. J Hepatobiliary Pancreat Sci (2012) 0.81
Hepatoprotective effect of ulinastatin in a rat model of major hepatectomy after obstructive jaundice. Dig Dis Sci (2015) 0.81
Bone and brain metastases from ampullary adenocarcinoma. World J Gastroenterol (2009) 0.80
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials. Oncotarget (2013) 0.80
Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy. World J Gastroenterol (2013) 0.80
Left hepatectomy accompanied by a resection of the whole caudate lobe using the dorsally fixed liver-hanging maneuver. Surg Today (2011) 0.79
Laparoscopic radical cholecystectomy for suspected early gall bladder carcinoma: thinking beyond convention. Surg Endosc (2015) 0.79
A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1. Gut Liver (2013) 0.78
Characteristics of bile duct carcinoma with superficial extension in the epithelium. World J Surg (2009) 0.78
Xanthogranulomatous cholecystitis: Difficulty in differentiating from gallbladder cancer. World J Gastroenterol (2015) 0.77
Impact of Type of Surgery on Survival Outcome in Patients With Early Gallbladder Cancer in the Era of Minimally Invasive Surgery: Oncologic Safety of Laparoscopic Surgery. Medicine (Baltimore) (2016) 0.76
Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma. BMC Gastroenterol (2016) 0.75
The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma. PLoS One (2016) 0.75
Lower incidence of complications in endoscopic nasobiliary drainage for hilar cholangiocarcinoma. World J Gastrointest Endosc (2016) 0.75
Surgical outcomes and prognostic factors influencing long-term survival in patients with gallbladder cancer. Korean J Hepatobiliary Pancreat Surg (2012) 0.75
Poorly cohesive adenocarcinoma of the ampulla of Vater: a case report. Surg Case Rep (2016) 0.75
Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer. Gut Liver (2016) 0.75
Preoperative diagnosis of an asymptomatic cancer restricted to the cystic duct. Int J Surg Case Rep (2014) 0.75
Current Role of Minimally Invasive Radical Cholecystectomy for Gallbladder Cancer. Gastroenterol Res Pract (2016) 0.75
Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma. HPB (Oxford) (2015) 0.75
Synchronous Gall Bladder and Bile Duct Cancer: A Short Series of Seven Cases and a Brief Review of Literature. J Clin Exp Hepatol (2016) 0.75
A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer. Int J Clin Oncol (2011) 0.75
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93
Management strategies in resection for hilar cholangiocarcinoma. Ann Surg (1992) 3.69
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology (1997) 3.28
Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg (2003) 3.16
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg (1990) 2.86
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg (2000) 2.55
Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg (1996) 2.35
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients. Arch Surg (1999) 2.20
Research into the results of resection of hilar bile duct cancer. Surgery (1990) 2.18
Tumor seeding following laparoscopy: international survey. World J Surg (1999) 2.18
Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg (2003) 2.04
Criteria for safe hepatic resection. Am J Surg (1995) 2.03
Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg (2003) 2.03
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99
Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg (2001) 1.99
Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg (2000) 1.82
Surgical management of hilar cholangiocarcinoma. Ann Surg (2005) 1.80
Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg (1992) 1.80
Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg (2006) 1.76
Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg (2002) 1.75
Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery (1994) 1.73
Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer (2005) 1.70
Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg (1992) 1.69
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg (2006) 1.64
Depth of subserosal invasion predicts long-term survival after resection in patients with T2 gallbladder carcinoma. Ann Surg Oncol (2003) 1.60
Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery (2007) 1.54
Laparoscopic cholecystectomy can disseminate in situ carcinoma of the gallbladder. J Am Coll Surg (1995) 1.54
Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol (2000) 1.52
Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet (1986) 1.49
Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery (1998) 1.47
What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer (1997) 1.43
Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology (1995) 1.43
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol (2005) 1.43
Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg (2001) 1.41
One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg (2000) 1.40
"Anatomic" right hepatic trisectionectomy (extended right hepatectomy) with caudate lobectomy for hilar cholangiocarcinoma. Ann Surg (2006) 1.39
Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery (2004) 1.39
Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology (2004) 1.38
Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion. Surgery (1995) 1.38
Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery (1996) 1.38
Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg (1999) 1.37
Lymph node spread from carcinoma of the gallbladder. Cancer (1997) 1.37
Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg (2005) 1.37
Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg (1996) 1.35
Carcinoma of the ampulla of vater. A clinicopathologic study and pathologic staging of 109 cases of carcinoma and 5 cases of adenoma. Cancer (1987) 1.33
Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery (2005) 1.32
Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery (1996) 1.30
Extensive surgery for carcinoma of the gallbladder. Br J Surg (2002) 1.28
The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer (1997) 1.27
Early gallbladder carcinoma does not warrant radical resection. Br J Surg (2001) 1.27
Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg (2002) 1.26
Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg (2003) 1.21
Complications of percutaneous transhepatic portal vein embolization. J Vasc Interv Radiol (2002) 1.18
Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg (2002) 1.17
Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract. World J Surg (1993) 1.16
Laparoscopic cholecystectomy for polypoid lesions of the gallbladder: a clinicopathologic study. Surg Laparosc Endosc Percutan Tech (2001) 1.15
Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg (1999) 1.15
Incidence of port site recurrence after laparoscopic cholecystectomy for preoperatively unsuspected gallbladder carcinoma. Surgery (1998) 1.15
The management of tumors of the ampulla of Vater by local resection. Ann Surg (1996) 1.14
Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results. Cancer (1997) 1.12
Arterioportal shunting as an alternative to microvascular reconstruction after hepatic artery resection. Br J Surg (2004) 1.12
Incidental carcinoma of the gallbladder. Eur J Surg Oncol (2002) 1.09
Radical surgery for advanced gallbladder carcinoma. Br J Surg (1996) 1.07
Carcinoma of the periampullary region: who benefits from portal vein resection? Am J Surg (1996) 1.05
Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery (1997) 1.05
Carcinoma of the ampulla of Vater. Br J Surg (1986) 1.05
Perineural invasion has a negative impact on survival of patients with gallbladder carcinoma. Br J Surg (2002) 1.05
Appraisal of surgical treatment for pT2 gallbladder carcinomas. World J Surg (2004) 1.04
Clinical behavior and prognostic factors of periampullary adenocarcinoma. Ann Surg (1995) 1.03
Appraisal of surgical resection of gallbladder cancer with special reference to lymph node dissection. Langenbecks Arch Surg (2000) 1.03
Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases. Ann Surg (2007) 1.03
Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg (2000) 1.01
Five-year survivors after aggressive surgery for stage IV gallbladder cancer. J Hepatobiliary Pancreat Surg (2001) 1.00
Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg (2008) 0.99
Gallbladder cancer: an analysis of a series of 139 patients with invasion restricted to the subserosal layer. J Gastrointest Surg (2006) 0.99
Factors influencing postoperative hospital mortality and long-term survival after radical resection for stage IV gallbladder carcinoma. World J Surg (2003) 0.98
Portal vein resection and reconstruction prior to hepatic dissection during right hepatectomy and caudate lobectomy for hepatobiliary cancer. Br J Surg (2003) 0.97
Should suspected early gallbladder cancer be treated laparoscopically? J Gastrointest Surg (2002) 0.96
Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with gallbladder carcinoma. Ann Surg (2006) 0.95
Wide local excision as an alternative treatment for periampullary carcinoma. Am J Gastroenterol (1987) 0.94
CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer. J Gastroenterol (2005) 0.93
Pathogenesis and treatment of neoplastic diseases of the papilla of Vater: Kausch-Whipple procedure with lymph node dissection in cancer of the papilla of Vater. J Hepatobiliary Pancreat Surg (2004) 0.92
Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg (2007) 0.91
Still any role for transduodenal local excision in tumors of the papilla of Vater? J Hepatobiliary Pancreat Surg (2004) 0.91
Extended cholecystectomy for carcinoma of the gallbladder. World J Surg (1995) 0.91
Portal vein resection for hilar cholangiocarcinoma. Am Surg (2006) 0.91
Gallbladder carcinoma in the era of laparoscopic cholecystectomy. Arch Surg (1996) 0.88
Port site metastases from gallbladder cancer after laparoscopic cholecystectomy. Results of a Swedish survey and review of published reports. Eur J Surg (1999) 0.88
Is local excision of pT1-ampullary carcinomas justified? Eur J Surg Oncol (1996) 0.88
Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer. J Am Coll Surg (2001) 0.87
Outcome of radical surgery for stage IV gallbladder carcinoma. J Hepatobiliary Pancreat Surg (2007) 0.87
Routes of hepatic metastasis of gallbladder carcinoma. Am J Clin Pathol (1998) 0.87
Renal function is well maintained after use of left renal vein graft for vascular reconstruction in hepatobiliary-pancreatic surgery. J Am Coll Surg (2005) 0.83
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet (2012) 4.84
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist (2010) 4.68
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study. Lancet Oncol (2011) 3.44
Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol (2013) 3.26
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg (2011) 2.88
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer (2011) 2.81
let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis (2008) 2.75
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol (2015) 2.70
Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg (2015) 2.63
Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am (2009) 2.53
Unroofed coronary sinus syndrome: diagnosis, classification, and surgical treatment. J Thorac Cardiovasc Surg (2003) 2.50
Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36
Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism. J Clin Oncol (2007) 2.35
Intrahepatic cholangiocarcinoma with predominant "ductal plate malformation" pattern: a new subtype. Am J Surg Pathol (2012) 2.25
CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol (2004) 2.25
TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 2.23
Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep (2011) 2.09
Factors affecting the accuracy of endoscopic transpapillary sampling methods for bile duct cancer. Dig Endosc (2013) 2.09
Management strategy for biliary stricture following laparoscopic cholecystectomy. J Hepatobiliary Pancreat Sci (2014) 2.03
Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg (2003) 2.03
Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene (2002) 2.01
Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg (2004) 1.99
Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci (2012) 1.98
Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol (2010) 1.98
Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.98
An extended dysfunctional area in the congestive area of the remnant liver after hemi-hepatectomy with middle hepatic vein resection for liver cancers evaluated on the gadoxetic acid disodium-enhanced magnetic resonance imaging. J Hepatobiliary Pancreat Sci (2013) 1.97
New invagination procedure for pancreaticojejunostomy using only four sutures. World J Surg (2012) 1.97
Efficacy of stone density on noncontrast computed tomography in predicting the outcome of extracorporeal shock wave lithotripsy for patients with pancreatic stones. Pancreas (2015) 1.97
Prevention of esophageal stricture after endoscopic submucosal dissection using tissue-engineered cell sheets. Gastroenterology (2012) 1.95
Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics Proteomics (2006) 1.94
Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg (2008) 1.93
Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischaemia induced by percutaneous coronary intervention. Eur Heart J (2005) 1.92
Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci (2007) 1.90
Surgical anatomy of the bile ducts at the hepatic hilum as applied to living donor liver transplantation. Ann Surg (2004) 1.90
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res (2012) 1.84
TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.84
TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.82
Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression. Int J Cancer (2009) 1.80
Molecular loops in the galactic center: evidence for magnetic flotation. Science (2006) 1.76
Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas (2004) 1.76
Eap45 in mammalian ESCRT-II binds ubiquitin via a phosphoinositide-interacting GLUE domain. J Biol Chem (2005) 1.68
Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg (2008) 1.68
Progenitors of skeletal muscle satellite cells express the muscle determination gene, MyoD. Dev Biol (2009) 1.66
TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.66
Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol (2005) 1.64
Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg (2007) 1.64
Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol (2004) 1.59
A late phase II study of S-1 for metastatic pancreatic cancer. Cancer Chemother Pharmacol (2007) 1.59
Immunoglobulin G4-related periaortitis complicated by aortic rupture and aortoduodenal fistula after endovascular AAA repair. J Endovasc Ther (2014) 1.59
Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.58
Vascular endothelial growth factor in children with congenital heart disease. Ann Thorac Surg (2003) 1.57
Clinical utility of intraductal US to decrease early recurrence rate of common bile duct stones after endoscopic papillotomy. J Gastroenterol Hepatol (2008) 1.56
Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) (2011) 1.56
Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01). Jpn J Clin Oncol (2008) 1.55
Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society. Pancreas (2007) 1.54
Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery (2007) 1.54
TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.53
Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol (2002) 1.52
Risk factors for alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan. Liver Transpl (2014) 1.52
General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc (2010) 1.51
Diagnostic value of magnetic resonance cholangiopancreatography for clinically suspicious spontaneous passage of bile duct stones. J Gastroenterol Hepatol (2007) 1.49
UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Res (2003) 1.49
New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci (2012) 1.49
Surgical treatment of patients with acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.49